We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+1.56%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$31.3B
AUM Growth
+$1.67B
Cap. Flow
+$1.83B
Cap. Flow %
5.84%
Top 10 Hldgs %
37.77%
Holding
1,441
New
112
Increased
695
Reduced
355
Closed
81

Top Buys

Rank Stock Value
1
PLTR icon
Palantir
PLTR
+$698M
2
NFLX icon
Netflix
NFLX
+$243M
3
VTR icon
Ventas
VTR
+$232M
4
META icon
Meta Platforms (Facebook)
META
+$184M
5
AMZN icon
Amazon
AMZN
+$153M

Sector Composition

Rank Sector Weight
1 Technology 30.75%
2 Real Estate 25.79%
3 Communication Services 11.7%
4 Consumer Discretionary 7.26%
5 Financials 6.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TSHA icon
1251
Taysha Gene Therapies
TSHA
$1.61B
$4K ﹤0.01%
691
-21,129
-97% -$103K
URGN icon
1252
UroGen Pharma
URGN
$1.97B
$4K ﹤0.01%
160
USIG icon
1253
iShares Broad USD Investment Grade Corporate Bond ETF
USIG
$17.3B
$4K ﹤0.01%
80
XLF icon
1254
State Street Financial Select Sector SPDR ETF
XLF
$56.5B
$4K ﹤0.01%
72
RAPP
1255
Rapport Therapeutics
RAPP
$1.96B
$4K ﹤0.01%
121
ORKA
1256
Oruka Therapeutics
ORKA
$5.31B
$4K ﹤0.01%
116
SEPN
1257
Septerna Inc
SEPN
$1.51B
$4K ﹤0.01%
+149
New +$3.56K
AMLX icon
1258
Amylyx Pharmaceuticals
AMLX
$2.19B
$3K ﹤0.01%
266
AQST icon
1259
Aquestive Therapeutics
AQST
$452M
$3K ﹤0.01%
500
ARVN icon
1260
Arvinas
ARVN
$530M
$3K ﹤0.01%
252
COLL icon
1261
Collegium Pharmaceutical
COLL
$1.18B
$3K ﹤0.01%
67
-60
-47% -$2.51K
CSTL icon
1262
Castle Biosciences
CSTL
$742M
$3K ﹤0.01%
86
DAWN
1263
DELISTED
Day One Biopharmaceuticals
DAWN
$3K ﹤0.01%
296
GERN icon
1264
Geron
GERN
$898M
$3K ﹤0.01%
2,247
GHRS icon
1265
GH Research
GHRS
$1.92B
$3K ﹤0.01%
+207
New +$2.82K
GLUE icon
1266
Monte Rosa Therapeutics
GLUE
$1.82B
$3K ﹤0.01%
203
IOVA icon
1267
Iovance Biotherapeutics
IOVA
$2.04B
$3K ﹤0.01%
1,006
JANX icon
1268
Janux Therapeutics
JANX
$912M
$3K ﹤0.01%
187
KROS icon
1269
Keros Therapeutics
KROS
$197M
$3K ﹤0.01%
133
KURA icon
1270
Kura Oncology
KURA
$793M
$3K ﹤0.01%
297
MGTX icon
1271
MeiraGTx Holdings
MGTX
$1.08B
$3K ﹤0.01%
330
DFTX
1272
Definium Therapeutics
DFTX
$5.6B
$3K ﹤0.01%
242
NVAX icon
1273
Novavax
NVAX
$1.21B
$3K ﹤0.01%
492
OMER icon
1274
Omeros
OMER
$845M
$3K ﹤0.01%
191
PCRX icon
1275
Pacira BioSciences
PCRX
$1.04B
$3K ﹤0.01%
128
-41
-24% -$975

Similar funds

Daiwa Securities Group's Q4 2025 Portfolio in Review

As of Q4 2025, Daiwa Securities Group held 1,441 positions worth $31.3B, up 5.6% from $29.6B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Daiwa Securities Group deployed $1.83B of net new capital in Q4 2025, opening 112 new positions and adding to 695 existing holdings. Its largest new stake was iShares Bitcoin Trust: 1,895,000 shares worth $94.1M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 30% a quarter earlier, followed by Real Estate and Communication Services.

On the sell side, the largest reduction was ServiceNow, an estimated $542M trimmed.

  • Daiwa Securities Group's largest Q4 2025 buy was iShares Bitcoin Trust: 1,895,000 shares worth $94.1M.
  • Daiwa Securities Group added most to Palantir in Q4 2025, an estimated $698M increase.
  • Daiwa Securities Group's biggest Q4 2025 reduction was ServiceNow, cutting an estimated $542M.
  • Daiwa Securities Group fully exited Eagle Materials in Q4 2025, selling an estimated $12.8M.
  • Daiwa Securities Group's ten largest holdings make up 38% of its $31.3B portfolio in Q4 2025.
  • Daiwa Securities Group opened 112 new positions and closed 81 in Q4 2025.
  • Daiwa Securities Group's portfolio value rose 5.6% quarter-over-quarter to $31.3B.

Based on Daiwa Securities Group's 13F filing for Q4 2025, filed 11 Feb 2026.